SIRT1 and glioblastoma: A previous study also confirmed that miR-22 could inhibit cell proliferation by targetting the 3′-UTR of SIRT1 in glioblastoma could inhibit cell proliferation and miR-22-SIRT1 pathway was a potential target for glioblastoma treatment [43].